Publication | Closed Access

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

Hematological MalignancyOncologyAcute Leukemia PatientsMedicineMalignant Blood DisorderMixed-phenotype Acute LeukemiaHematologyPathologyLaboratory MedicineWt1 ExpressionAdult T-cell Leukemia-lymphomaMolecular DiagnosticsRadiation OncologyCancer ResearchMinimal Residual DiseaseHealth Sciences